Indication
X-linked adrenoleukodystrophy
X-linked adrenoleukodystrophy is a rare, inherited peroxisomal metabolic disorder caused by pathogenic variants in the ABCD1 gene, which impairs the beta-oxidation of very long-chain fatty acids. Read more about X-linked adrenoleukodystrophy
1 drugs 1 manufacturers
Drugs that treat it
Common X-linked adrenoleukodystrophy therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonX-linked adrenoleukodystrophy is a rare, inherited peroxisomal metabolic disorder caused by pathogenic variants in the ABCD1 gene, which impairs the beta-oxidation of very long-chain fatty acids.
This metabolic defect leads to systemic accumulation of these fatty acids, primarily targeting the white matter of the central nervous system, peripheral nerves, and the adrenal cortex.
While primarily affecting hemizygous males, heterozygous females may also exhibit manifestations with advancing age.
Clinical presentations range across distinct phenotypes, including rapidly progressive inflammatory cerebral demyelination leading to profound cognitive and motor deficits, a slowly progressive adult-onset myelopathy and axonopathy termed adrenomyeloneuropathy, and primary adrenocortical insufficiency.
- nih.gov
X-linked adrenoleukodystrophy is a rare, inherited peroxisomal metabolic disorder caused by pathogenic variants in the ABCD1 gene, which impairs the beta-oxidation of very long-chain fatty acids
- nih.gov
X-linked adrenoleukodystrophy is a rare, inherited peroxisomal metabolic disorder caused by pathogenic variants in the ABCD1 gene, which impairs the beta-oxidation of very long-chain fatty acids
- medlineplus.gov
This metabolic defect leads to systemic accumulation of these fatty acids, primarily targeting the white matter of the central nervous system, peripheral nerves, and the adrenal cortex
- nih.gov
This metabolic defect leads to systemic accumulation of these fatty acids, primarily targeting the white matter of the central nervous system, peripheral nerves, and the adrenal cortex While primarily affecting hemizygous males, heterozygous females may also exhibit manifestations with advancing age Clinical presentations range across distinct phenotypes, including rapidly progressive inflammatory cerebral demyelination leading to profound cognitive and motor deficits, a slowly progressive adult...
- rarediseases.org
This metabolic defect leads to systemic accumulation of these fatty acids, primarily targeting the white matter of the central nervous system, peripheral nerves, and the adrenal cortex
- rareportal.org.au
While primarily affecting hemizygous males, heterozygous females may also exhibit manifestations with advancing age
- meduniwien.ac.at
Clinical presentations range across distinct phenotypes, including rapidly progressive inflammatory cerebral demyelination leading to profound cognitive and motor deficits, a slowly progressive adult-onset myelopathy and axonopathy termed adrenomyeloneuropathy, and primary adrenocortical insufficiency
Personalize your experience
Follow X-linked adrenoleukodystrophy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.